Leonteq Securities’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
Leonteq Securities's ACAD Position: Q3 2026 in Review
Leonteq Securities reduced its Acadia Pharmaceuticals (ACAD) stake by 16% in Q3 2026, selling an estimated $7.68K and leaving 1,546 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #859.
Leonteq Securities first reported a position in ACAD in Q4 2020 and has held it in 9 quarters since. The position peaked at $367K in Q4 2020. 269 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Leonteq Securities held 1,546 shares of Acadia Pharmaceuticals worth $31.2K as of Q3 2026.
- Leonteq Securities sold 286 Acadia Pharmaceuticals shares in Q3 2026, an estimated $7.68K.
- Acadia Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #859 holding.
- Leonteq Securities first reported a position in Acadia Pharmaceuticals in Q4 2020 and has held it in 9 quarters since.
- Leonteq Securities's Acadia Pharmaceuticals position peaked at $367K in Q4 2020.
- 269 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.